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Abstract
Brain mitochondrial carrier protein-1 (BMCP1), a new member of the mitochondrial uncoupling carrier, has been shown
to be expressed predominantly in the brain of the mice and humans. We cloned rat BMCP1 cDNA and investigated its
mRNA level during postnatal development and under various metabolic conditions. The nucleotide sequence of the cDNA
revealed that rat BMCP1 protein was composed of 322 amino acid residues, and was 99 and 96% identical to the mouse and
human proteins and 29, 33 and 35% identical to rat uncoupling protein (UCP) 1, UCP2 and UCP3, respectively. The
molecular weight was predicted to be 36 017 Da and the protein of this size was detectable when the cDNA was expressed in
vitro. Using Northern blot analysis, the corresponding mRNA, approximately 1.8-kb in size, was found expressed
predominantly in the cerebrum, cerebellum and hypothalamus. A unique developmental pattern was identified in the brain,
where BMCP1 expression was low in their fetal life, but significantly elevated in the first postnatal week. Thereafter BMCP1
mRNA was maintained to be gradually increased. In 48-h fasted or insulin-induced hypoglycemic rats, BMCP1 mRNA
expression in the hypothalamus slightly, but significantly, decreased compared with that in their appropriate controls. The
present results indicate that BMCP1 may be involved in pathogenesis of mitochondrial dysfunction in neurons induced by
aging or neurodegenerative disorders, and perhaps in energy balance in the brain. ß 2000 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Uncoupling proteins (UCPs) in the inner mito-
chondrial membrane are unique in the ability to dis-
sipate the proton electrochemical gradient generated
by respiratory activity [1^6]. The proteins thus func-
tion to uncouple mitochondrial respiration from
ATP synthesis [1,2]. UCP1 is expressed exclusively
in brown adipose tissue (BAT), a crucial site in ther-
mogenesis and energy expenditure in rodents [7,8].
Unlike UCP1, UCP2 is widely expressed in the hu-
man and rodent tissues [4,5], and UCP3 is preferen-
tially expressed in skeletal muscle and BAT [9,10].
Our previous report has demonstrated that UCP2
mRNA is also expressed in the rat hypothalamus
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[11]. A recent study on in situ hybridization histo-
chemistry detected an intense signal for UCP2
mRNA in the hypothalamus of mouse, particularly
in the suprachiasmatic nucleus, the paraventricular
hypothalamic nucleus, the arcuate nucleus, the dorsal
motor nucleus of the vagus nerve, and the choroid
plexus [12]. Taken together, the speci¢cally localized
expression of UCP2 mRNA in the hypothalamus
suggests that the protein may play some essential
roles in those neurons, although the details of its
physiological role are still uncertain.
The brain mitochondrial carrier protein-1
(BMCP1), a novel member of the UCP family re-
cently cloned, is predominantly expressed in the cen-
tral nervous systems in the mice and humans [13]. In
situ hybridization analysis has shown it is particu-
larly abundant in the cortex, hippocampus, thala-
mus, amygdala, and hypothalamus. The predicted
amino acid sequence of BMCP1 revealed low level
of identity with the other UCPs. When expressed in
yeast; however, BMCP1 possessed marked uncou-
pling activity, resulting in a decrease in mitochon-
drial membrane potential [13].
The decrease in mitochondrial membrane potential
is important evidence explaining impending apopto-
sis of neuronal cells in response to aging or neuro-
degenerative disorders [14^16]. From this viewpoint,
we cloned rat BMCP1 cDNA and investigated as to
whether BMCP1 may be modulated at its mRNA
level along developmental periods of fetal and post-
natal lives. We also investigated its implication in
brain energy expenditure using fasted or insulin-in-
duced hypoglycemic rats, since there have been nu-
merous reports that UCPs expression is regulated by
dietary and hormonal manipulations [4,6,17^21].
2. Materials and methods
2.1. Animals
Male Wistar King A (WKA) rats at 12 weeks of
age were used in the present study. WKA fetal rats,
postnatal rat pups and adult rats were used in the
developmental experiment. Animals were housed in a
sound-proof room illuminated daily from 07:00 to
19:00 h (a 12:12-h light:dark cycle) and maintained
at 21 þ 1‡C with humidity at 55 þ 5%. They were al-
lowed free access to tap water and standard pellet rat
chow (CE-2, CLEA Japan, Tokyo, Japan), unless
otherwise stated.
2.2. Preparation of fasted, insulin-induced
hypoglycemic and STZ-DM rats
Fasted rats were prepared by deprivation of food
for 48-h with free access to tap water. Hypoglycemic
rats were made by treatment with daily subcutaneous
injections of 3 U insulin (Lente Iszilin; Shimizu, Shi-
zuoka, Japan) for 3 days. Streptozotocin-induced di-
abetic (STZ-DM) rats were made by injecting STZ
(Sigma, St. Louis, MO, USA) into the tail vein at a
dose of 60 mg/kg under light ether anesthesia and
were sacri¢ced 12 days after the injection. Blood
samples were collected from each rat through a
chronically indwelling silicone catheter implanted in
the right external jugular vein [22]. Serum samples
were immediately frozen at 320‡C until serum me-
tabolites were measured. Serum insulin concentration
was quanti¢ed using an insulin radioimmunoassay
kit (Rat insulin [125I] assay system; Amersham,
Buckinghamshire, UK). Concentration of Serum glu-
cose and free fatty acids (FFA) was measured with
commercially available kits (Merckauto Glucose;
Kanto, Tokyo, Japan, NEFA-SS’Eiken’; Eiken, To-
kyo, Japan).
2.3. Tissue preparation and total RNA extraction
After rats were sacri¢ced, various tissues including
the cerebrum, cerebellum, hypothalamus, heart, lung,
kidney, liver, spleen, stomach, large intestine, small
intestine, testis, skeletal muscle, BAT, and epididy-
mal white adipose tissue (WAT) were surgically dis-
sected to investigate the tissue-speci¢c expression of
BMCP1. In the developmental experiment, whole
brain was surgically removed from fetal rats at the
18th day of pregnancy, postnatal rat pups consisting
of the 1st and 4th day, and the 1st, 2nd and 4th week
of age, and adult rats consisting of 10 and 28 weeks
of age (four for each group). The hypothalamus tak-
en from fasted, STZ-DM and insulin-induced hypo-
glycemic rats and their appropriate controls (¢ve for
each group) was also used in the experiments under
various metabolic conditions. The tissue samples
were immediately frozen in liquid nitrogen to be
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stored at 380‡C until use. Total RNAs were ex-
tracted as previously described [23].
2.4. Cloning of rat BMCP1 cDNA using RT-PCR
and transcription and translation in vitro
Total RNA (1 Wg) from WKA rat hypothalamus
was reverse-transcribed by oligo(dT)12ÿ18 priming us-
ing Moloney murine leukemia virus reverse tran-
scriptase (Life Technologies, Gaithersburg, USA).
The single-strand cDNAs were subjected to PCR
for cloning of rat BMCP1 cDNA. For ampli¢cation
of rat BMCP1 cDNA, we prepared a set of primers,
P1 and P2 (sense primer P1, 5P-CCGAGGAACTG-
GCAAGATC-3P and antisense primer P2, 5P-TGG-
GCTGATGGGTTTCCAG-3) which were speci¢c
for the sequence of the mouse BMCP1 cDNA [13].
PCR was carried out with Taq DNA polymerase
(Amersham, Buckinghamshire, UK) and 20 pmol
each of the sense and antisense primers. The reaction
pro¢le was as follows: denaturation at 94‡C for
1 min, annealing at 58‡C for 1 min, and extension at
72‡C for 1 min, for 30 cycles. The PCR products of
approximately 1000-bp were subcloned into pCR II
vector (TA cloning kit; Invitrogen, San Diego, USA)
for sequencing. The nucleotide sequences were deter-
mined by the dideoxynucleotide chain termination
method, using synthetic oligonucleotide primers
which were complementary to the vector sequence
and ABI373A automated DNA Sequencing System
(Perkin-Elmer, Norwalk, USA). All DNA sequences
were con¢rmed by reading both DNA strands.
BMCP1 full-length cDNAs inserted into pCR II
vector (pCR-rBMCP1) were linearized by digestion
with restriction enzymes BamHI or EcoRV for the
transcription of sense or antisense RNA, respectively.
Sense and antisense RNAs were transcribed and
capped in vitro with T7 and Sp6 RNA polymerase,
respectively, using a Message Machine kit (Ambion,
Austin, USA). The resulting RNA was translated in a
rabbit reticulocyte lysate system (Promega, Madison,
USA) in the presence of [35S]methionine. The trans-
lation products were electrophoresed in a 12.5% poly-
acrylamide gel and detected by £uorography.
2.5. Northern blot analysis
Total RNAs (20 Wg/lane) were electrophoresed on
1.2% formaldehyde-agarose gel, and the RNAs that
were separated were transferred onto a Biodyne B
membrane (Pall Canada, Mississauga, Ont., Canada)
in 20USSC by capillary blotting [24], and immobi-
lized by exposure to ultraviolet light (0.8 J). Prehy-
bridization and hybridization were carried out as de-
scribed [25], using the 32P-labeled 1043-bp DNA
fragment excised after digesting pCR-rBMCP1 with
EcoRI restriction enzyme, as a probe. Membranes
were washed under high stringency conditions [24].
After washing the membranes, the hybridization sig-
nals were analyzed with a BIO-image analyzer BAS
2000 (Fuji Film Institution, Tokyo, Japan).
The band intensities obtained by Northern blots
were normalized to those of 18S ribosomal RNAs.
The results were expressed as % changes þ S.E.M. of
the mean appropriate control values taken as
100%.
2.6. Statistical analysis
Data were expressed as the mean þ S.E.M. The
statistical signi¢cance between two groups was as-
sessed by Student’s unpaired t-test and among
more than three groups by one-way analysis of
variance followed by Sche¡e’s multiple comparison
test.
3. Results
3.1. Cloning of rat BMCP1 cDNA and transcription
and translation in vitro
To obtain the nucleotide sequence of rat BMCP1
cDNA, RT-PCR was carried out using total RNA
from WKA rat hypothalamus as a template. Sequen-
ces of both strands were determined for more than
95% of the cDNA fragment. Analysis of the deduced
amino acid sequence revealed that rat BMCP1 was a
protein composed of 322 amino acid residues and
was 99 and 96% identical to the mouse and human
counterparts, and 29, 33 and 35% identical to rat
UCP1, 2 and 3, respectively, as shown in Fig. 1.
Transcription and translation in vitro was carried
out using the cloned cDNA and a protein product
of approximately 36 kDa that is of expected size was
synthesized by SDS-PAGE.
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3.2. Expression levels of BMCP1 mRNA in various
tissues of rats
The tissue-speci¢c pattern of rat BMCP1 mRNA
expression was characterized by Northern blot anal-
ysis. As shown in Fig. 2, BMCP1 mRNA was highly
expressed in rat brain, including the cerebrum, cere-
bellum and hypothalamus as a 1.8-kb mRNA. In
addition to the primary expression in the brain, lesser
levels of BMCP1 mRNA were present, in the heart,
lung, kidney and some other tissues.
Fig. 1. Alignment of the predicted amino acid sequences of rat BMCP1 and the other UCPs. The amino acids residues conserved
among these four uncoupling carriers are shaded. Six putative transmembrane domains are underlined and labeled I^VI. Three mito-
chondrial carrier motifs are indicated by dots and the putative purine nucleotide binding site is indicated by asterisks. Amino acid
numbers are to the right. Gaps are inserted to maximize homology.
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3.3. Developmental alteration of BMCP1 mRNA
expression in the rat brain
As shown in Fig. 3, BMCP1 mRNA levels in the
whole brain rapidly increased by 2.0-fold to reach a
¢rst peak in the ¢rst postnatal week (P6 0.05), and
increased again with the advance of aging, and were
greater by 2.3-fold in the 10th postnatal week
(P6 0.005) and by 3.2-fold in the 28th postnatal
week (P6 0.0001) compared to fetal levels. UCP2
mRNA levels in the brain remained low in the fetal
life, but gradually increased along with postnatal de-
velopment peaking in the ¢rst postnatal week by 2.2-
fold compared with the fetal level (P6 0.05). After
the fourth postnatal week, UCP2 mRNA began to
decrease and returned to the fetal level.
Fig. 2. Tissue distribution of rat BMCP1 mRNA. A representative Northern blot analysis is shown. Total RNAs (20 Wg/lane) from
various tissues in male Wistar King A rats were analyzed. The 28S ribosomal RNA bands visualized with ethidium bromide are
shown in the bottom panel.
6
Fig. 3. Developmental alterations of BMCP1 and UCP2
mRNA expression in the brain of fetal rats, postnatal rat pups
and adult rats. (A) Representative Northern blots of BMCP1
and UCP2. Total RNAs (20 Wg/lane) in various stages of life
were used. (B) Time course changes in developmental mRNA
expression of BMCP1 and UCP2. Closed circles and open
squares indicate the mRNA levels in BMCP1 and UCP2, re-
spectively. Values, the mean þ S.E.M. (n = 4 for each). F, the fe-
tal life time on the 18th day of pregnancy; 1D and 4D, the 1st
and 4th postnatal days; 1W, 2W, 4W, 10W and 28W, the 1st,
2nd, 4th, 10th and 28th postnatal weeks. *P6 0.05,
**P6 0.005, ***P6 0.0001 vs. the corresponding fetal value.
2P6 0.05, 3P6 0.01, 4P6 0.005 vs. the corresponding value at
the 1st postnatal week.
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3.4. Regulatory expression of BMCP1 mRNA levels
under various metabolic conditions
Fasted rats decreased their body weight (ad libi-
tum-fed group vs. fasted group, 320 þ 4 vs. 282 þ 2 g,
P6 0.0001), concentration of serum glucose (119 þ 3
vs. 78 þ 6 mg/dl, P6 0.0001) and serum insulin
(6.9 þ 0.4 vs. 3.1 þ 0.5 ng/ml, P6 0.0001), but in-
creased serum FFA (0.38 þ 0.03 vs. 0.88 þ 0.02
mEq/l, P6 0.0001). The level of BMCP1 mRNA in
the hypothalamus was decreased by 20% in 48-h
fasted rats compared with that in the ad libitum-
fed controls (P6 0.05).
The insulin-induced hypoglycemic rats increased
their body weight (PBS control group vs. insulin-in-
duced hypoglycemic group, 314 þ 3 vs. 331 þ 5 g,
P6 0.05), but decreased serum glucose (109 þ 6 vs.
33 þ 8 mg/dl, P6 0.001) and serum FFA
(0.40 þ 0.03 vs. 0.20 þ 0.01 mEq/l, P6 0.0005) 3 days
after daily insulin treatment. The STZ-DM rats de-
creased their body weight (citrate-bu¡ered control
group vs. STZ-DM group, 340 þ 4 vs. 256 þ 5 g,
P6 0.0001) and serum insulin (8.1 þ 1.3 vs. 2.2 þ 0.6
ng/ml, P6 0.001), but increased serum glucose
(102 þ 2 vs. 519 þ 16 mg/dl, P6 0.0001) and serum
FFA (0.41 þ 0.05 vs. 0.79 þ 0.04 mEq/l, P6 0.001)
12 days after STZ treatment. BMCP1 mRNA level
in the hypoglycemic rats was decreased by 22% com-
pared with that in the PBS controls (P6 0.01), leav-
ing the BMCP1 mRNA level of the STZ-DM rats
una¡ected.
4. Discussion
In the present study, we cloned rat BMCP1
cDNA. The protein was comprised of 323 amino
acid residues, and the molecular weight was calcu-
lated to be 36 017 Da, the value close to that esti-
mated with SDS-PAGE. The predicted amino acid
sequence of rat BMCP1 was less homologous to
those of other UCP family members, but conserved
six putative transmembrane domains, three mito-
chondrial transporter protein signature motifs and
a putative nucleotide binding site as with other
UCPs [4,5,9,10,26]. Together with these ¢ndings,
the results indicate potently that rat BMCP1 is a
member of the mitochondrial proton-transporter
proteins.
To con¢rm tissue-speci¢c characteristics of the rat
BMCP1 gene, we compared expression levels of the
mRNA in various tissues of rat. BMCP1 mRNA was
predominantly expressed in various parts of the rat
brain, such as the cerebrum, cerebellum and hypo-
thalamus. These ¢ndings were consistent with the
tissue distribution of mouse and human BMCP1 [13].
To assess the putative role of brain UCPs during
perinatal development and aging, we analyzed
BMCP1 and UCP2 expression in the whole brain
of the fetus, postnatal rat pups and adult rats. In
the present study, both BMCP1 and UCP2 mRNA
levels in the brain remained low in the fetus, but they
gradually increased along toward postnatal develop-
ment peaking in the ¢rst postnatal week. Then
BMCP1 expression continued to increase with aging,
and was greater in the 28th week than in fetal life,
while UCP2 expression decreased and returned to the
fetal level after the fourth postnatal week. This ex-
pression pattern of the BMCP1 gene has been found
to be markedly di¡erent from that of UCP2 in the
present study and the other UCPs in the BAT and
heart of rodents [27,28]. Therefore, the speci¢c rise of
BMCP1 expression in old rats indicates that this
protein has a certain role in aging of neuronal cells.
There is mounting evidence for mitochondrial in-
volvement not only in neurodegenerative disorders,
but also in normal aging [14^16]. Electron transport
chain (ETC) functioning was found to be impaired in
these disorders and aging [14^16], leading to reduc-
tion in ATP production, formation of free-radicals,
altered calcium handling and opening of the mito-
chondrial permeability transition pore, an event
linked to cell death in neurons [14,15]. Mitochondrial
uncoupling carriers decrease the electron potential of
the mitochondrial inner membrane [1^6,13] resulting
from proton leakage and participate in energy dissi-
pation by uncoupling respiratory chain function
from ATP synthesis. There is no direct evidence link-
ing up-regulation of BMCP1 expression to aging.
One possible explanation is that it may be associated
with mitochondrial ETC dysfunction which leads to
apoptosis of the neuronal cells.
Fasting is well known to modulate UCPs expres-
sion [6,17,18]. The level of BMCP1 mRNA in hypo-
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thalamus slightly, but signi¢cantly, decreased in the
48-h fasted rats compared with the ad libitum-fed
controls. To further investigate key factors in the
regulation of BMCP1, we assessed concentrations
of hypothalamic BMCP1 in STZ-DM and insulin-
induced hypoglycemic rats. Akin to fasting, STZ-
DM produced hypoinsulinemia and hyper-free fatty
acidemia, but did hyperglycemia in contrast to fast-
ing. The expression of BMCP1 mRNA in STZ-DM
rats was left una¡ected. Conversely, BMCP1 mRNA
level in the hypoglycemic group decreased compared
with that in the PBS controls. The following idea is
still greatly in need of experimental veri¢cation;
however, these results assume that a decrease in glu-
cose concentration may be one of the regulators for
BMCP1 expression. Indeed, glucose is a principal
energy source for the mammalian brain. The down-
regulation of BMCP1 in response to hypoglycemia
may play a homeostatic role under energy de¢ciency
in the brain.
In summary, we isolated a cDNA encoding rat
BMCP1 and determined the sequence. BMCP1 ex-
pression in the whole brain was increased with the
advance of aging. BMCP1 may thus be involved in
the pathogenesis of mitochondrial dysfunction in
neurons along with aging or neurodegenerative dis-
eases.
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